Literature DB >> 24311292

Functional characterization of zebrafish K2P18.1 (TRESK) two-pore-domain K+ channels.

Ann-Kathrin Rahm1, Felix Wiedmann, Jakob Gierten, Constanze Schmidt, Patrick A Schweizer, Rüdiger Becker, Hugo A Katus, Dierk Thomas.   

Abstract

The human KCNK18 gene is predominantly expressed in brain, spinal cord, and dorsal root ganglion neurons. Encoded K2P18.1K(+) channels are functionally implicated in migraine, pain and anesthesia. Data delineating the in vivo significance of K2P18.1 are still limited owing to a lack of model systems allowing for rapid, whole organism phenotypic analyses. We hypothesized that zebrafish (Danio rerio) might close this scientific gap. This work was designed to characterize the zebrafish ortholog of K2P18.1 in comparison to human K2P18.1 channels. The complete coding sequence of zKCNK18 was amplified from zebrafish cDNA. Zebrafish KCNK18 expression was assessed by in situ hybridization. Human and zebrafish K2P18.1 currents were functionally analyzed using two-electrode voltage clamp electrophysiology and the Xenopus oocyte expression system. KCNK18 mRNA is expressed in zebrafish brain and eyes. Human and zebrafish K2P18.1 proteins share 32 % identity. Zebrafish K2P18.1 channels mediate K(+)-selective background currents that stabilize the negative resting membrane potential. Functional similarities between human and zK2P18.1 currents include open rectification properties, inhibition by barium, and regulation by signaling molecules protein kinase (PK)C, PKA, and phospholipase C. In contrast to the human ortholog, zK2P18.1 exhibited reduced sensitivity to elevation of intracellular calcium levels by ionomycin and was virtually insensitive to inhibition by quinidine. Zebrafish and human K2P18.1 channels share functional and regulatory properties, indicating that the zebrafish may serve as model to assess K2P18.1 function in vivo. However, distinct differences in K2P18.1 current regulation require careful consideration when zebrafish data are extrapolated to human physiology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24311292     DOI: 10.1007/s00210-013-0945-1

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  43 in total

1.  Potent activation of the human tandem pore domain K channel TRESK with clinical concentrations of volatile anesthetics.

Authors:  Canhui Liu; John D Au; Hilary Liao Zou; Joseph F Cotten; C Spencer Yost
Journal:  Anesth Analg       Date:  2004-12       Impact factor: 5.108

2.  A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura.

Authors:  Ronald G Lafrenière; M Zameel Cader; Jean-François Poulin; Isabelle Andres-Enguix; Maryse Simoneau; Namrata Gupta; Karine Boisvert; François Lafrenière; Shannon McLaughlan; Marie-Pierre Dubé; Martin M Marcinkiewicz; Sreeram Ramagopalan; Olaf Ansorge; Bernard Brais; Jorge Sequeiros; Jose Maria Pereira-Monteiro; Lyn R Griffiths; Stephen J Tucker; George Ebers; Guy A Rouleau
Journal:  Nat Med       Date:  2010-09-26       Impact factor: 53.440

3.  Discrete change in volatile anesthetic sensitivity in mice with inactivated tandem pore potassium ion channel TRESK.

Authors:  Yun Jeong Chae; Jianan Zhang; Paul Au; Marta Sabbadini; Guo-Xi Xie; C Spencer Yost
Journal:  Anesthesiology       Date:  2010-12       Impact factor: 7.892

Review 4.  Zebrafish: a model system for the study of human disease.

Authors:  K Dooley; L I Zon
Journal:  Curr Opin Genet Dev       Date:  2000-06       Impact factor: 5.578

5.  TRESK background K(+) channel is inhibited by phosphorylation via two distinct pathways.

Authors:  Gábor Czirják; Péter Enyedi
Journal:  J Biol Chem       Date:  2010-03-09       Impact factor: 5.157

6.  Optical probing of a dynamic membrane interaction that regulates the TREK1 channel.

Authors:  Guillaume Sandoz; Sarah C Bell; Ehud Y Isacoff
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

Review 7.  Migraine: Role of the TRESK two-pore potassium channel.

Authors:  Ronald G Lafrenière; Guy A Rouleau
Journal:  Int J Biochem Cell Biol       Date:  2011-08-09       Impact factor: 5.085

8.  PIP2 hydrolysis underlies agonist-induced inhibition and regulates voltage gating of two-pore domain K+ channels.

Authors:  Coeli M B Lopes; Tibor Rohács; Gábor Czirják; Tamás Balla; Péter Enyedi; Diomedes E Logothetis
Journal:  J Physiol       Date:  2005-01-27       Impact factor: 5.182

9.  Anesthetic properties of the ketone bodies beta-hydroxybutyric acid and acetone.

Authors:  Liya Yang; Jing Zhao; Pavle S Milutinovic; Robert J Brosnan; Edmond I Eger; James M Sonner
Journal:  Anesth Analg       Date:  2007-09       Impact factor: 5.108

10.  Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels.

Authors:  Constanze Schmidt; Felix Wiedmann; Patrick A Schweizer; Rüdiger Becker; Hugo A Katus; Dierk Thomas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-07-13       Impact factor: 3.000

View more
  8 in total

Review 1.  Properties, regulation, pharmacology, and functions of the K₂p channel, TRESK.

Authors:  Péter Enyedi; Gábor Czirják
Journal:  Pflugers Arch       Date:  2014-11-05       Impact factor: 3.657

2.  Modulation of K2P 2.1 and K2P 10.1 K(+) channel sensitivity to carvedilol by alternative mRNA translation initiation.

Authors:  J Kisselbach; C Seyler; P A Schweizer; R Gerstberger; R Becker; H A Katus; D Thomas
Journal:  Br J Pharmacol       Date:  2014-08-28       Impact factor: 8.739

3.  The LQLP calcineurin docking site is a major determinant of the calcium-dependent activation of human TRESK background K+ channel.

Authors:  Gábor Czirják; Péter Enyedi
Journal:  J Biol Chem       Date:  2014-09-08       Impact factor: 5.157

Review 4.  The Background K+ Channel TRESK in Sensory Physiology and Pain.

Authors:  Alba Andres-Bilbe; Aida Castellanos; Anna Pujol-Coma; Gerard Callejo; Nuria Comes; Xavier Gasull
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

5.  GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death.

Authors:  Jyh-Ming Jimmy Juang; Anna Binda; Shyh-Jye Lee; Juey-Jen Hwang; Wen-Jone Chen; Yen-Bin Liu; Lian-Yu Lin; Chih-Chieh Yu; Li-Ting Ho; Hui-Chun Huang; Ching-Yu Julius Chen; Tzu-Pin Lu; Liang-Chuan Lai; Shih-Fan Sherri Yeh; Ling-Ping Lai; Eric Y Chuang; Ilaria Rivolta; Charles Antzelevitch
Journal:  EBioMedicine       Date:  2020-07-07       Impact factor: 8.143

Review 6.  Two-Pore-Domain Potassium (K2P-) Channels: Cardiac Expression Patterns and Disease-Specific Remodelling Processes.

Authors:  Felix Wiedmann; Norbert Frey; Constanze Schmidt
Journal:  Cells       Date:  2021-10-27       Impact factor: 6.600

7.  Tubulin binds to the cytoplasmic loop of TRESK background K⁺ channel in vitro.

Authors:  Péter Enyedi; Irén Veres; Gabriella Braun; Gábor Czirják
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

Review 8.  Evolution of acid nociception: ion channels and receptors for detecting acid.

Authors:  Luke A Pattison; Gerard Callejo; Ewan St John Smith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-09-23       Impact factor: 6.237

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.